Answer:
Drug History Recording Form
Patient Name: AB Gender: Male Age: 80 years
Current Prescribed Medicines
(inc. inhalers/drops/creams and ointments)
Drug/route
Dose + Frequency
Date started
Indications
Any problems experienced
Citalopram
20 mg OD
28/7/15
Management of depressive episodes
NA
Lansoprazole
15 mg OD
28/7/15
Management of stomach and intestinal ulcer
NA
Finasteride
5 mg OD
28/7/15
Management of an enlarged prostrate
NA
HYLO Tear
1 drop q.d.s, p.r.n
28/7/15
Management of dry eye symptoms
NA
Ramipril capsule
10mg OD
28/7/15
Management of hypertension
NA
Sodium valproate Gastro-resistant tablet
500mg; the dosage starts at lowest effective dose and should be gradually increased until a control is achieved
28/7/15
Management of epilepsy
Hyperammonaemia
Atorvastatin
20mg nocte
28/7/15
Cholesterol lowering drug
NA
Cobalamine
50 mg OD
28/7/15
Management of low blood levels of the vitamin B12
NA
Linagliptine/Metformin
2.5mg/850mg 1 b.d
24/10/16
Management of type 2 diabetes mellitus
NA
Aspirin DBP
75mg
24/10/16
Control of diastolic blood pressure
NA
Drugs Recently Stopped
None
Over The Counter Preparations
Drug
Dose + frequency
Indications
Any problems experienced
None
Complementary medicines
(inc. herbal products/homeopathy/Chinese herbs, etc.)
Product
Dose + frequency
Indications
Any problems experienced
None
Allergies/Problems
Is the patient allergic to any medicine?
Comments- NKDA (No known drug allergies)
Social history
i) Units of alcohol a week= Occasionally consumes a glass of wine whiskey
ii) Cigarettes smoked a day = None
iii) Recreational drug use = None
Compliance Assessment
Provide an overview of whether you think the patient takes their medicine as prescribed. Identify any unintentional (e.g. forgot to take, unable to use/open product) or intentional
What concerns about medicines does patient have? What is the perceived benefit of taking medicines or non-adherence?
Comments
The patient last visited the doctor a month ago. The medicines are usually delivered by the pharmacy. The patient feels lethargic and tired most of the time. Symptoms of oversleeping are observed. He takes all medicines, prescribed by the specialist, carefully. The patient often engages in games such as, basketball, tennis and football. This can be attributed to the depressive episodes that he faces. He went for a review a couple of months ago. Diabetic assessments are carried out at an interval of every 3 months. He does not have any dietary restrictions. No compliance issues are identified.
PHARMACIST: …………………….. DATE: …………………………
SIGNATURE: ………………………..
Pharmaceutical Care Plan (Sheet 1)
Patient Data Collection
Data Collected 7th November
Demographic/Administration Information
Patient hospital number
Ward
Initials: AB
Age: 80 years
Ethnicity:
Gender : Male
Height (cm):
Weight (Kg): IBW: 24.4 kg/m2
SA:
Admission Date: 7/11/2017
Occupation: Retired Engineer
History of presenting complaint (HOPC)
Right foot thickened, helix toenail, pain since July 2010, fungal infection
Past Medical History/Surgery (PMH)
Suffered from stroke in 2009
High blood pressure
Type 2 diabetes since 2009
Has been suffering from depression since 2009
Suffered from blackout previously, after which he stopped driving
Strangulated hernia
Underwent a prostate operation more than 20 years ago
Has pain in the left knee; underwent operation in the left knee in November 2015
Family and Social History
Lives with his wife lives in a flat. He used to enjoy gardening before. He finds it difficult to walk alone now. He has 3 children. 1 lives in the UK and 2 others in Australia. He has been suffering from hearing impairment since 2016. He faces difficulty to walk due to severe back pain. He uses a stick to walk and a corset for hernia. He also suffers from poor eyesight. Manifests symptoms of tremor and shiver.
Examination findings
Days 1-3
Day 4 onwards
Medical problems
Acute/chronic
Active Yes / No
Depression
Chronic
Yes
Stomach and intestinal ulcer
Acute
Yes
Enlarged prostrate
Acute
Yes
Essential hypertension
Chronic
Yes
Dry eye
Acute
Yes
Type 2 diabetes mellitus
Chronic
Yes
Epilepsy
Chronic
Yes
High cholesterol
Chronic
Yes
Vitamin B12 deficiency
Chronic
Yes
Drug Serum Concentrations:
Drug
Date
Pharmaceutical Care Plan (Sheet 2)
Current Medication & Compliance Problems
Current Drug Therapy
Drug/route
Dose + Frequency
Duration (Start-Stop dates)
Indications/comments
1. Citalopram
20 mg OD
28/7/15; continue
Management of depressive episodes. It should not be given in doses beyond 40mg, and all signs of suicidal ideations and worsening of depression should be immediately reported to the doctor. It is also essential to check blood electrolyte levels regularly.
2. Lansoprazole
15 mg OD
28/7/15; continue
Management of stomach and intestinal ulcer. It should be taken at least 30 minutes before having food. The tablet should not be chewed or crushed inside the mouth. The doctor should be immediately consulted if symptoms of spasm, muscle cramp and seizures appear.
3. Finasteride
5 mg OD
28/7/15; continue
Management of an enlarged prostrate. All kinds of sudden changes in the breast tissues such as, pain and lumos should be immediately reported. The patient package insert should be read before its administration. The doctor should be informed of the medication, if PSA levels are monitored.
4. HYLO Tear
1 drop q.d.s, p.r.n
28/7/15; continue
Management of dry eye symptoms. Sufficient quantity of the eye drop should be slowly administered into the eye. Administration should be immediately stopped if the drop appears discoloured or cloudy. The doctor should be consulted if a dose of HYLO Tear is missed.
5. Ramipril capsule
10mg OD
28/7/15; continue
Management of hypertension. It should be ensured that the patient is adequately hydrated. The medicine cannot be stopped even if normal blood pressure levels are achieved. The entire capsule should be swallowed whole. Symptoms of light-headedness should be immediately reported.
6. Sodium valproate Gastro-resistant tablet
500mg; twice daily; the dosage starts at lowest effective dose and should be gradually increased until a control is achieved
28/7/15; continue
Management of epilepsy. It should be administered once in the morning and once in the evening. The ideal time gap should be between 10-12 hrs. If a dose is missed, it can be given any time within the next 12 hrs. The doctor should be contacted if signs of bleeding or bruising are observed.
7. Atorvastatin
20mg nocte
28/7/15; continue
Cholesterol lowering drug. The dosage can be increased or decreased depending on results of cholesterol tests that should be taken at an interval of 2-4 weeks. Alcohol and intake of grapefruits (whole or juice) should be limited. The TLC diet is recommended. Urgent medical advice should be taken if symptoms of trauma, seizures, and muscle pain are observed.
8. Cobalamine
50 mg OD
28/7/15; continue
Management of low blood levels of the vitamin B12.
9. Linagliptine/Metformin
2.5mg/850mg 1 b.d
24/10/16; continue
Management of type 2 diabetes mellitus. No doses should be missed. The medication should not be stopped even if blood glucose levels are normalized. 2 doses should not be taken at the same time. The doctor should be immediately called if rashes, blisters, peeling skin, tightness in chest and symptoms of pancreatitis are observed.
10. Aspirin DBP
75mg OD
24/10/16; continue
Control of diastolic blood pressure. It should be taken with food or after having meals. Care should be taken that the patient does not become dehydrated. Emergency help should be taken if a swelling in the neck or head, or breathing difficulty is observed.
COMMENTS/NOTES: (Potential compliance problems/compliance needs e.g. ‘What kind of system do you normally use to take your medicines at home?’)
Owing to the fact that the patient is on multiple medications, he is predisposed to increased likelihood of drug interactions. The carers should maintain a positive attitude and a light tone of voice while administering him medicines. The carers and nurses should keep their temper in check and should gently ask the reason why the patient is showing noncompliance to the medications. The medicines should be kept in dosette boxes that consists of a plastic system that will help to keep the weekly medicines organized. Using pill organizers may also help him in avoiding cases drug dosage miss. Blister pack kits should be used for packing the medications.
Pharmaceutical Care Plan (Sheet 3)
Problem List + Action Plan
Patient: Mr. Ab Student: Date: 9th November
Date
Pharmaceutical problem / Cause of problem
Action/Intervention
Intended outcome/monitoring
Adherence of Ramipril capsules that are dispensed outside the pill organizers and dosette box
The patient should be given counselling on the necessity of timely administration of the prescribed drugs. The patient also needs to be counselled on the importance of completing the therapy to prevent health complications.
Monitor the blood pressure minutely until it gets stabilized.
Adherence to sodium valproate gastro-resistant tablets throughout life
The dosage of sodium valproate that is correct for the patient should be worked out. This anti-seizure drug will not be withdrawn at any time (10).
Monitor the presence of complications such as, increased suicidal ideations, anxiety and idiosyncratic abnormalities (11). Regularly monitor for nutritional intake, fluid intake and somnolence.
Use of lansoprazole in case of ulcers in the stomach and intestine
The patient should be checked for lactose intolerance before administering the medicine. The capsule will be opened and the granules will be mixed with water or juice if he faces difficulty in swallowing it (17).
Monitor for diarrhea, allergic reactions, stomach pain and increased heart rate (8). The dosage will be immediately stopped if such side effects are observed.
Use of citalopram as an effective therapeutic intervention for depression
This selective serotonin reuptake inhibitor (SSRI) is administered for inducing a feeling of wellbeing and the patient will be administered the drug until symptoms of persistent low mood disappears (3).
Monitor for symptoms of nausea, irritability and headache on withdrawal of the drug (2).
Evidence for use of metformin and linagliptine to treat type 2 diabetes mellitus
Administer 850 mg metformine or 2.5mg linagliptine twice a day for controlling the blood glucose levels (6). Advise the patient to strictly adhere to the medications to prevent elevation of blood sugar.
The active ingredient metformin hydrochloride lowers the amount of sugar produced by the liver (1). Linagliptine along with exercise and diet lowers the glucose content (15). Monitor for rapid pulse, anxiety and muscle tremor.
Evidence for administration of lubricating eye drop HYLO Tear, for dry eye sensation
0.1% Sodium Hyaluronate helps in maintaining optimal viscosity (16). The patient should be reminded of taking the drops on a regular basis.
The chemical provides a soothing and long lasting relief to moderate dry eye symptoms (12). Monitor for redness or swelling in eye.
Adherence to atorvastatin tablets for maintenance of the blood cholesterol levels
Statin or HMG CoA reductase inhibitors reduce bad cholesterol and triglycerides and increase good cholesterol levels (5). The patient should be educated on appropriate use of medicine from his pill organizer, failure to which may cause heart attack.
Monitor for breathing difficulties and swelling of the face and neck. Check for rapid pulse rate if patient misses doses.
Evidences for use of cobalamine in treating vitamin B12 deficiency
Serum cobalamin levels <200 ng/L are common among the elderly and can be reversed by administration of intramuscular cobalamine therapy (4). Monitor for cobalamine toxicity and analphylactic reactions (9). Adherence to aspirin medications for reducing high blood pressure The patient should be counselled on the necessity of timely administration of aspirin, which otherwise may increase the risk of suffering from stroke. Effective prevention of cardiovascular events on administration of low doses of aspirin (13). Monitor for hemorrhagic stroke and gastric bleeding symptoms. Adherence to finasteride monotherapy for treating prostate hyperplasia in the patient Adherence to the medication will result in better urine flow and decrease the urge of the patient to urinate (7). The medication will be continued until enlargement of the prostate gland reduces. Follow the medication until benefits are noticed after a year or more. Monitor for symptoms of prostate cancer, bloating, cold sweats and rapid weight gain (14). References Aroda VR, Christophi CA, Edelstein SL, Zhang P, Herman WH, Barrett-Connor E, Delahanty LM, Montez MG, Ackermann RT, Zhuo X, Knowler WC. The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up. The Journal of Clinical Endocrinology & Metabolism. 2015 Apr 1;100(4):1646-53. Bet PM, Hugtenburg JG, Penninx BW, Hoogendijk WJ. Side effects of antidepressants during long-term use in a naturalistic setting. European neuropsychopharmacology. 2013 Nov 30;23(11):1443-51. Bould H, Wiles N, Potokar J, Cowen P, Nutt DJ, Peters TJ, Lewis G. Does baseline fatigue influence treatment response to reboxetine or citalopram in depression? An open label randomized controlled trial. Journal of Psychopharmacology. 2012 May;26(5):663-9. Devalia V, Hamilton MS, Molloy AM. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. British journal of haematology. 2014 Aug 1;166(4):496-513. Friedland SN, Leong A, Filion KB, Genest J, Lega IC, Mottillo S, Poirier P, Reoch J, Eisenberg MJ. The cardiovascular effects of peroxisome proliferator-activated receptor agonists. The American journal of medicine. 2012 Feb 29;125(2):126-33. Haak T, Meinicke T, Jones R, Weber S, Eynatten MV, Woerle HJ. Initial combination of linagliptin and metformin improves glycaemic control in type 2 diabetes: a randomized, double?blind, placebo?controlled study. Diabetes, Obesity and Metabo 2012 Jun 1;14(6):565-74. Irwig MS. Persistent sexual side effects of finasteride: could they be permanent?. The journal of sexual medicine. 2012 Nov 1;9(11):2927-32. Johnson DA, Oldfield EC. Reported side effects and complications of long-term proton pump inhibitor use: dissecting the evidence. Clinical gastroenterology and hepatology. 2013 May 1;11(5):458-64. Lachner C, Steinle NI, Regenold WT. The neuropsychiatry of vitamin B12 deficiency in elderly patients. The Journal of neuropsychiatry and clinical neurosciences. 2012 Jan;24(1):5-15. Liu X, Wu Y, Chen Z, Ma M, Su L. A systematic review of randomized controlled trials on the theraputic effect of intravenous sodium valproate in status epilepticus. International Journal of Neuroscience. 2012 Apr 30;122(6):277-83. Malamiri RA, Ghaempanah M, Khosroshahi N, Nikkhah A, Bavarian B, Ashrafi MR. Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial. european journal of paediatric neurology. 2012 Sep 30;16(5):536-41. Moshirfar M, Pierson K, Hanamaikai K, Santiago-Caban L, Muthappan V, Passi SF. Artificial tears potpourri: a literature review. Clinical ophthalmology (Auckland, NZ). 2014;8:1419. NICE Guidance. Myocardial infarction: cardiac rehabilitation and prevention of further cardiovascular disease. 2013 November; CG172. Rick FG, Abi-Chaker A, Szalontay L, Perez R, Jaszberenyi M, Jayakumar AR, Shamaladevi N, Szepeshazi K, Vidaurre I, Halmos G, Krishan A. Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist. Proceedings of the National Academy of Sciences. 2013 Feb 12;110(7):2617-22. Ross SA, Rafeiro E, Meinicke T, Toorawa R, Weber-Born S, Woerle HJ. Efficacy and safety of linagliptin 2.5 mg twice daily versus 5 mg once daily in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, placebo-controlled trial. Current medical research and opinion. 2012 Sep 1;28(9):1465-74. Schmidl D, Witkowska K, Werkmeister RM, Wozniak P, Bata A, Fondi K, Baar C, Garhofer G, Schmetterer L. Effect of gel-based artificial tears on tear film thickness in patients with dry eye disease. Investigative Ophthalmology & Visual Science. 2016 Sep 26;57(12):2881-2887. Sugano K, Kontani T, Katsuo S, Takei Y, Sakaki N, Ashida K, Mizokami Y, Asaka M, Matsui S, Kanto T, Soen S. Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial. Journal of gastroenterology. 2012 May 1;47(5):540-52.